Published in Hepatitis Weekly, April 19th, 2004
The treatment combines embolization, blocking the blood supply to the tumor, with radiofrequency ablation, killing the tumor with heat. This combination is effective at treating solitary hepatocellular carcinoma lesions affords patients survival benefits on par with surgical resection, but without the trauma.
The minimally invasive interventional treatment targets only the tumor tissue, and spares the healthy tissue. In addition to being equally effective,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.